Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Clinical trial NCT02812641 · UNKNOWN

Trial details

NCT number: NCT02812641
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Esophageal Squamous Cell Carcinoma

Start date: 2016-06-01
Primary completion: 2019-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.